Finance

Lists
002004:SHE
Huapont Life Sciences Co Ltd
CNÂĄ4.48
-1.97%
(-0.090) 1D
Oct 12, 3:04:48 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002004...
Open
CNÂĄ4.55
High
CNÂĄ4.60
Low
CNÂĄ4.46
Mkt. cap
9.05B
Avg. vol.
29.17M
Volume
32.70M
Dividend
7.81%
Quarterly dividend
CNÂĄ0.09
Ex-dividend date
Sep 23, 2026
P/E ratio
13.76
52-wk high
CNÂĄ6.08
52-wk low
CNÂĄ3.88
EPS
CNÂĄ0.33
Shares outstanding
1.98B
No. of employees
12K
Open
CNÂĄ4.55
High
CNÂĄ4.60
Low
CNÂĄ4.46
Mkt. cap
9.05B
Avg. vol.
29.17M
Volume
32.70M
Dividend
7.81%
Quarterly dividend
CNÂĄ0.09
Ex-dividend date
Sep 23, 2026
P/E ratio
13.76
52-wk high
CNÂĄ6.08
52-wk low
CNÂĄ3.88
EPS
CNÂĄ0.33
Shares outstanding
1.98B
No. of employees
12K
News stories
From web sources and news partners
About Huapont Life Sciences Co Ltd
CEO-
Employees12K
FoundedMar 11, 1992
Headquarters-
SectorFertilizer
Websitehuapont.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.14B
2.43B
2.82B
3.09B
Cost of goods sold
1.91B
1.62B
1.81B
1.90B
Cost of revenue
1.91B
1.62B
1.81B
1.90B
Research and development expenses
84.45M
59.62M
76.27M
100.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
624.76M
505.73M
524.21M
618.82M
Operating expense
701.68M
696.38M
630.98M
780.27M
Total operating expenses
2.62B
2.32B
2.44B
2.68B
Operating income
524.79M
105.95M
380.09M
410.93M
Other non operating income
34.41M
-37.96M
-27.33M
22.12M
EBT including unusual items
396.39M
-29.47M
320.93M
396.34M
EBT excluding unusual items
450.75M
30.80M
324.13M
382.06M
Income tax expense
66.83M
-31.27M
80.02M
110.17M
Effective tax rate
16.86%
106.10%
24.93%
27.80%
Other operating expenses
-14.08M
74.59M
20.43M
42.72M
Net income
223.36M
101.37M
154.83M
164.51M
Net profit margin
7.11%
4.18%
5.49%
5.32%
Earnings per share
-
-
-
-
Interest and investment income
-
49.65M
26.75M
53.26M
Interest expense
-83.41M
-84.80M
-55.38M
-57.64M
Net interest expenses
-83.41M
-35.14M
-28.64M
-4.38M
Depreciation and amortization charges
-
-
-
-
EBITDA
756.49M
360.27M
634.41M
659.29M
Gain or loss from assets sale
12.01M
-10.05M
-
-3.26M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps